KYMR - Company ID 0001815442
As of 2026-07-09, Kymera Therapeutics, Inc. (KYMR) has a market capitalization of $9.79 B, making it the #969 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-07-09 | $9.79 B |
| 2026-07-08 | $9.81 B |
| 2026-07-07 | $9.91 B |
| 2026-07-06 | $9.44 B |
| 2026-07-05 | $9.34 B |
| 2026-07-04 | $9.34 B |
| 2026-07-03 | $9.34 B |
| 2026-07-02 | $9.34 B |
| 2026-07-01 | $9.52 B |
| 2026-06-30 | $9.55 B |
| 2026-06-29 | $9.11 B |
| 2026-06-28 | $8.89 B |
As of 2026-07-09, Kymera Therapeutics, Inc. (KYMR) has a market capitalization of $9.79 B, making it the #969 most valuable US-listed company.
Kymera Therapeutics, Inc. is the #969 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-06-27 | $8.89 B |
| 2026-06-26 | $9.04 B |
| 2026-06-25 | $9.58 B |
| 2026-06-24 | $8.24 B |
| 2026-06-23 | $8.08 B |
| 2026-06-22 | $8.18 B |
| 2026-06-21 | $7.44 B |
| 2026-06-20 | $7.44 B |
| 2026-06-19 | $7.44 B |
| 2026-06-18 | $7.45 B |
| 2026-06-17 | $7.31 B |
| 2026-06-16 | $7.01 B |
| 2026-06-15 | $7.19 B |
| 2026-06-14 | $7.09 B |
| 2026-06-13 | $7.09 B |
| 2026-06-12 | $7.09 B |
| 2026-06-11 | $6.80 B |
| 2026-06-10 | $6.44 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.